Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SKP2 | Q13309 | 1/20 | 0.49 |
| ▸ | POLA1 | P09884 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 4/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.44 |
| ▸ | MAPT | P10636 | 3/20 | 0.44 |
| ▸ | TP53 | P04637 | 2/20 | 0.44 |
| ▸ | XBP1 | P17861 | 1/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | ATM | Q13315 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | UNG | P13051 | 3/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20288325 | 0.83 | SKP2 (0.43) | SKP2POLA1HPGDSMN1; SMN2MAPT | |
| SCHEMBL27619358 | 0.82 | MAPT (0.57) | SKP2POLA1HPGDSMN1; SMN2MAPT | |
| SCHEMBL14127779 | 0.80 | HPGD (0.58) | HPGDSMN1; SMN2MAPTTP53XBP1 | |
| SCHEMBL48879 | 0.80 | HPGD (0.58) | HPGDSMN1; SMN2MAPTTP53XBP1 | |
| SCHEMBL3437558 | 0.79 | HPGD (0.51) | SKP2POLA1HPGDSMN1; SMN2MAPT | |
| SCHEMBL14127780 | 0.79 | HPGD (0.49) | HPGDSMN1; SMN2MAPTTP53XBP1 | |
| SCHEMBL1422741 | 0.78 | HPGD (0.54) | HPGDSMN1; SMN2MAPTTP53XBP1 | |
| SCHEMBL14372957 | 0.76 | MAPT (0.54) | HPGDSMN1; SMN2MAPTTP53HTT | |
| SCHEMBL22701343 | 0.76 | EGFR (0.41) | ALDH1A1L3MBTL1LMNAMAPK1 | |
| SCHEMBL2542906 | 0.75 | HPGD (0.46) | SKP2HPGDSMN1; SMN2MAPTTP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220016009-A1 | SYMMETRIC AZOMETHINE DIRECT DYES, PROCESS FOR THEIR PREPARATION, COSMETIC COMPOSITION COMPRISING AT LEAST ONE SUCH DYE AND USE THEREOF | L'OREAL (FR) | 2022-01-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220016009-A1 | SYMMETRIC AZOMETHINE DIRECT DYES, PROCESS FOR THEIR PREPARATION, COSMETIC COMPOSITION COMPRISING AT LEAST ONE SUCH DYE AND USE THEREOF | KRT18, IK, H1-5 | SKP2 2028/4885POLA1 1212/4885HPGD 1959/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.